Higher plasma levels of GFAP and NfL have been associated with more MTA in Aβ-positive patients with subjective cognitive impairment, mild cognitive impairment and dementia, as well as with CVD in incident dementia [16, 17]. This evidence concerns the gene GFAP and dementia.